Public Alert No: 0014/2019 – Expanded Recall Of Losartan Potassium 50mg And 100mg Tablets By Teva Pharmaceuticals USA
, The National Agency for Food and Drug Administration and Control(NAFDAC) has been informed that Teva Pharmaceuticals USA, Inc has expanded its voluntary consumer-level recall originally initiated on April 25,2019. This expanded recall includes 7 lots of bulk losartan potassium USP tablets and its due to the detection of an impurity –N-Nitroso-N-Methyl-4-aminobutyric acid (NMBA) that […]
Public Alert No: 0013/2019 – Recall Of Beast Capsules By Stiff Boy LLC
, The National Agency for Food and Drug Administration and Control has been informed by the United States Food and Drug Administration that (US FDA) that STIFF BOY LLC is voluntarily recalling Beast capsules due to presence of undeclared Sildenafil. Sildenafil is a drug used for the treatment of male erectile dysfunction and is in […]
